New guidelines aim to improve the delivery of prostate cancer survival care
Recommendations to support primary care some 2.8 million men with a history prostate US cancer
guidelines Company New American prostate cancer Survivorship care published today outlines after treatment follow-up clinical care for long-term and late effects myriad about 2.8 million US prostate cancer survivors may face.
The guidelines are based on recommendations made by a panel of experts from the American Cancer Society convened as part of the National Resource Centre work on Surviving Cancer, a project of the ACS. They are designed to promote optimal health and quality of life for the survivors of prostate cancer after treatment by facilitating the delivery of comprehensive post-treatment care by primary care clinicians.
prostate cancer survivors are more than four out of ten survivors of cancer in men and one in five of all cancer survivors in the United States. Although guidelines exist for the treatment and monitoring of recurrent diseases, availability of guidelines for long-term post-treatment care is limited. Survivorship Guidelines American Cancer Society Cancer Care prostate have been developed using a combined approach to the synthesis of evidence and expert consensus. They address the health promotion, surveillance of recurrence and screening for primary secondary cancers, and assessing and managing long-term physical and psychological late effects resulting from prostate cancer and its treatment. A major challenge for the development of guidelines has been the limited availability of published data informing the clinical management of survivors of prostate cancer after treatment of
The recommendations :.
- Since information needs evolve than treatment patients transition through different stages of information requirements survival, survivor and caregivers should be evaluated regularly, with information and support services supplied or designated as necessary.
-
clinicians primary care should provide regular assessments of the survivors to determine appropriate levels of participation in modification programs to promote health and lifestyle.
-
clinicians primary care should conduct routine assessments Body Mass Index among survivors across the continuum of survival from prostate cancer, with recommendations to limit consumption 'calorie foods and drinks for the survivors who are overweight or obese.
-
primary care clinicians should educate survivors regarding the association between physical activity and mortality in general and cancer of the prostate and lower quality of life improved.
-
Since smoking after prostate cancer treatment increases the risk of cancer recurrence and second cancers, primary care clinicians should assess for smoking and offer or refer survivors to the cessation advice and resources.
-
Although existing data are not definitive regarding the frequency of monitoring for recurrence using PSA testing, an important clinical guidelines, the guidelines NCCN for the treatment of prostate cancer recommend measuring serum PSA levels every 6 to 12 months for the first 5 years after the final treatment, then recheck each year.
-
Clinicians should be aware of a small increased risk of second primary cancers after radiotherapy compared with men receiving surgery. While the evidence does not support the frequency or intensity of screening, respect for ACS routine screening guidelines for early detection of new cancers is recommended increased
-
survivors should be evaluated for physical (ex .: urinary, sexual and bowel) and the psychosocial effects of prostate cancer and its treatment; the focus of the assessment should be appropriate to the treatment of cancer and received the current state of the disease to trigger the appropriate self-management and clinical management strategies to support and therapy.
-
Estimates indicate that as many 30% of patients with cancer experience clinically relevant prostate general distress, 25% increased anxiety, and experience nearly 10% major depressive disorder. The guidelines say early identification, treatment and ongoing assessment of the psychological distress of important aspects of prostate cancer survivorship care.
"We hope that the hard work that went into the development of these much needed guidelines will pay off in improved care for the 240,000 men diagnosed with cancer prostate each year, "said Rebecca Cowens-Alvarado, MPH, principal investigator for the National resource Centre survival to cancer, strategy director of cancer control of the mission to the American cancer Society and co-author of report. "the adoption of these guidelines will be crucial to improve the delivery of prostate cancer survival care."
EmoticonEmoticon